| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.088 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.094 | 0.05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.036 | 0.5 |